Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose Finding Study of Gadavist in Myocardial Perfusion MRI
NCT01490294Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2004
- Primary completion
- May 2006
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of gadobutrol in coronary artery disease (CAD), sponsored by Bayer. Started Mar 2004; status: completed.
02
Drugs
gadobutrol
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT01490294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01490294.